News
FDA approves AZ's Farxiga in new heart failure prevention us...
The FDA has approved AstraZeneca’s diabetes drug Farxiga to reduce the chances of hospitalisations for heart failure in adults with type 2 diabetes and other cardiovascular risks.<
